Pharmacokinetics and pharmacodynamics of phosphodiesterase-III inhibitors
- 31 December 1990
- journal article
- research article
- Published by Elsevier in Journal of Cardiothoracic Anesthesia
- Vol. 4 (6) , 7-11
- https://doi.org/10.1016/0888-6296(90)90226-6
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- THE EFFECT OF AMRINONE ON INDICES OF LEFT VENTRICULAR DIASTOLIC FUNCTION ASSESSED BY VOLUME (CONDUCTANCE) CATHETERAnesthesiology, 1988
- The Pharmacokinetics and Pharmacodynamics of Newer Inotropic AgentsClinical Pharmacokinetics, 1987
- New Positive Inotropic Agents in the Treatment of Congestive Heart FailureNew England Journal of Medicine, 1986
- Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failureThe American Journal of Cardiology, 1986
- Clinical safety of intravenous amrinone—A reviewThe American Journal of Cardiology, 1985
- Intravenous amrinone in left ventricular failure complicated by acute myocardial infarctionThe American Journal of Cardiology, 1985
- Amrinone in the management of low cardiac output after open heart surgeryThe American Journal of Cardiology, 1985
- Assessment of the inotropic and vasodilator effects of amrinone versus isoproterenolThe American Journal of Cardiology, 1984
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.Circulation, 1980